Tranexamic Acid Tablet
Product Images NDC 69918-301

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 69918-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nordic Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tranexamic 01)

Chemical structure of tranexamic acid, depicting a cyclohexane ring with amino and carboxylic acid functional groups attached at specific carbon atoms.*

FDA Label Image

Figure 1 (Tranexamic 02)

A line graph depicting mean menstrual blood loss (mL) over treatment periods including baseline and multiple cycles for two groups: Tranexamic Acid 3900 mg/day and placebo. The graph compares 3-cycle and 6-cycle study data, showing changes in blood loss from baseline through six treatment cycles.*

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

Label for Tranexamic Acid, USP Tablets 650 mg oral tablets, containing 30 tablets per bottle. The label shows the NDC 69918-301-30 and indicates the product is Rx only. It is manufactured for Amring Pharmaceuticals Inc. and by Mikart, LLC. Storage instructions and usual adult dosage information are partially visible.*

FDA Label Image

Company Label (Tranexamic 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.